Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced the closing of a Series C funding round raising $105 million.
Patients More Satisfied With AI’s Answers Than Those From Their Doctor
Patients were consistently more satisfied with responses from artificial intelligence (AI) to messages in the electronic health record than they were with those from their